Search results
Xyphos and Poseida to develop allogeneic cell therapies for cancer
Pharmaceutical Technology via Yahoo Finance· 11 hours agoThe parties will combine their cell therapy platforms to create a new convertible chimeric antigen ...
FAS signalling pathway is crucial for CAR T cell persistence - Nature Reviews Immunology
Nature· 7 days agoChimeric antigen receptor (CAR) T cell therapies have revolutionized the treatment ...
Targeting myeloma essential genes using NOT Gated CAR T-cells, a computational approach - Leukemia
Nature· 3 days agoChimeric antigen receptor (CAR) T-cells have recently been demonstrated to be highly effective ...
Turning a tumor's 'shield' into a weapon against itself
Medical Xpress· 8 hours agoWang Lab researchers have now developed a new approach that turns a tumor cell's cunning defense...
Cell and gene therapy companies trip at scalability hurdle
Pharmaceutical Technology via Yahoo Finance· 4 days agoSince then, major strides have been made in the cell therapy space. The first chimeric antigen ...
Cytokine Release Syndrome: What to Know
Verywell Health via Yahoo News· 2 hours agoCytokine release syndrome (CRS) occurs when the immune system responds to infection or immunotherapy drugs more aggressively than it should. Learn more...
...Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop Novel...
The West Side Index & Gustine Press-Standard· 20 hours agoPoseida is advancing differentiated cell and gene therapies with the capacity to cure certain cancers and rare diseases.
Biomarkers identified for successful treatment of bone marrow tumors
Medical Xpress· 6 days agoCAR T cell therapy has proven effective in treating various hematological cancers. In a clinical study, researchers ...
CD70 Antibodies CD70 Targeting Therapies Clinical Trials Market Opportunity Insight
Benzinga· 1 day agoDelhi, May 01, 2024 (GLOBE NEWSWIRE) -- Global CD70 Targeting Therapies Market Opportunity & Clinical Trials Insight 2024 Report Highlights: CD70 Targeting Therapies In Clinical Trials: > 20 TherapiesCD 70
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 15 hours agoPlanegg/Martinsried, May 2, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of